# Safety of Nitroglycerin for Field Treatment of STEMI

> **NCT02407002** · — · COMPLETED · sponsor: **Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center** · enrollment: 940 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02407002
- **Lead sponsor:** Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-12-31
- **Final completion:** 2017-04-30
- **Target enrollment:** 940 (ACTUAL)
- **Last updated:** 2017-08-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02407002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02407002, "Safety of Nitroglycerin for Field Treatment of STEMI". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02407002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*